Russian journal of anaesthesiology and reanimatology 2, 2019 Клинические рекомендации фар


partum hemorrhage management: an Italian multidisciplinary attended pro-



Pdf көрінісі
бет26/28
Дата29.03.2023
өлшемі0,76 Mb.
#77132
1   ...   20   21   22   23   24   25   26   27   28
Байланысты:
Anestesiolog 2019 02 005


partum hemorrhage management: an Italian multidisciplinary attended pro-
tocol. Clin Ter. 2017;168(5):307-316.
98. Ahmadzia H, Phillips J, Katler Q, James A. Tranexamic Acid for Prevention 
and Treatment of Postpartum Hemorrhage: An Update on Management and 
Clinical Outcomes. Obstet Gynecol Surv. 2018;73(10):587-594. 
99. Vogel J, Oladapo O, Dowswell T, Gülmezoglu A. Updated WHO recom-
mendation on intravenous tranexamic acid for the treatment of post-par-
tum haemorrhage. Lancet Glob Health. 2018;6(1):18-19. 
100. Jadon A, Bagai R. Blood transfusion practices in obstetric anaesthesia. In-
dian J Anaesth
. 2014;58(5):629-636.
101. Meier J. Blood transfusion and coagulation management. Best Pract Res Clin 
Anaesthesiol
. 2016;30(3):371-379.
102. Kaufman R, Djulbegovic B, Gernsheimer T, Kleinman S, et al. AABB. Plate-
let transfusion: a clinical practice guideline from the AABB. Ann Intern Med
2015;162(3):205-213.
103. Waters J. Role of the massive transfusion protocol in the management of 
haemorrhagic shock. Br J Anaesth. 2014;113(Suppl 2):3-8.
104. National Blood Authority. Patient blood management guidelines: module 5-ob-
stetrics and maternity
. Canberra ACT (Australia): National Blood Authority; 
2015;129.
105. Prevention and Management of Postpartum Haemorrhage: Green-top Guide-
line No. 52. BJOG. 2017;124(5):106-149.
106. Bar-Natan M, Hymes K. Management of Intraoperative Coagulopathy. Neu-
rosurg Clin N Am.
2018;29(4):557-565.
107. Butwick A, Goodnough L. Transfusion and coagulation management in ma-
jor obstetric hemorrhage. Curr Opin Anaesthesiol. 2015;28(3):275-284.
108. Kwon J, MacLaren R. Comparison of Fresh-Frozen Plasma, Four-Factor 
Prothrombin Complex Concentrates, and Recombinant Factor VIIa to Fa-
cilitate Procedures in Critically Ill Patients with Coagulopathy from Liver 
Disease: A Retrospective Cohort Study. Pharmacotherapy. 2016;36(10):1047-
1054.
109. Brekelmans M, Ginkel K, Daams J, Hutten B, et al. Benefits and harms of 
4-factor prothrombin complex concentrate for reversal of vitamin K antag-
onist associated bleeding: a systematic review and metaanalysis. J Thromb 
Thrombolysis
. 2017;44(1):118-129.
110. Chai-Adisaksopha C, Hillis C, Siegal D, Movilla R, et al. Prothrombin com-
plex concentrates versus fresh frozen plasma for warfarin reversal. A system-
atic review and metaanalysis. Thromb Haemost. 2016;116(5):879-890.
111. Refaai M, Goldstein J, Lee M, Durn B, et al. Increased risk of volume 
overload with plasma compared with four-factor prothrombin com-
plex concentrate for urgent vitamin K antagonist reversal. Transfusion
2015;55(11):2722-2729.
112. Goldstein J, Refaai M, Milling TJr, Lewis B, et al. Four-factor prothrombin 
complex concentrate versus plasma for rapid vitamin K antagonist reversal in 
patients needing urgent surgical or invasive interventions: a phase 3b, open-
label, non-inferiority, randomised trial. Lancet. 2015;385(9982):2077-2087.
Клинические рекомендации ФАР 
FAR Clinical Recommendations


26
АНЕСТЕЗИОЛОГИЯ И РЕАНИМАТОЛОГИЯ 2, 2019
113. Johansen M, Wikkelsø A, Lunde J, Wetterslev J, Afshari A. Prothrombin com-
plex concentrate for reversal of vitamin K antagonist treatment in bleeding 
and non-bleeding patients. Cochrane Database Syst Rev. 2015;(7):CD010555.
114. Huber A, Raio L, Alberio L, Ghezzi F, Surbek D. Recombinant human fac-
tor VIIa prevents hysterectomy in severe postpartum hemorrhage: single cen-
ter study. J Perinat Med. 2011;40(1):43-49.
115. Phillips L, McLintock C, Pollock W, Gatt S, et al. Australian and New Zea-
land Haemostasis Registry. Recombinant activated factor VII in obstetric 
hemorrhage: experiences from the Australian and New Zealand Haemosta-
sis Registry. Anesth Analg. 2009;109(6):1908-1915.
116. Lavigne-Lissalde G, Aya A, Mercier F, Roger-Christoph S, et al. Recom-
binant human FVIIa for reducing the need for invasive second-line thera-
pies in severe refractory postpartum hemorrhage: a multicenter, randomized, 
open controlled trial. J Thromb Haemost. 2015;13(4):520-529.
117. Franchini M, Manzato F, Salvagno G, Lippi G. Potential role of recombi-
nant activated factor VII for the treatment of severe bleeding associated with 
disseminated intravascular coagulation: a systematic review. Blood Coagul Fi-


Достарыңызбен бөлісу:
1   ...   20   21   22   23   24   25   26   27   28




©emirsaba.org 2024
әкімшілігінің қараңыз

    Басты бет